polypeptide had a molecular weight of 15,000 daltons and accounted for more than 10% of the total E. coli proteins in fully induced cells; it was biologically active in the T-cell specific DNA synthesis assay, even after recovery from a SDS-containing polyacrylamide gel.
INTRODUCTION
Human interleukin 2 (IL2 or T-cell growth factor) is defined as a protein whose activity allows the long-term proliferation of T-cells following interaction with antigen (1) (2) (3) . It is an inducible protein synthesized and secreted by activated T-lymphocytes (4) and has been purified from various sources such as human peripheral blood lymphocytes (3, 5, 6) , tonsilar lymphocytes (7), spleen lymphocytes (8) , T-cell leukemia (9, 10) and T-cell hybridoma cultures (11, 12) . The molecular weight reported for the SDS-denatured human IL2 ranges from 12000 to 17000 (3, 11, 13) . It is believed that this molecular heterogeneity is dependent on the experimental conditions for the IL2 production (13) and may be explained perhaps by a variable degree of glycosylation (7, 14) . On the other hand, the finding that IL2 does not bind on a lectin column (3) would seem to indicate that the protein is unglycosylated. Recently, IL2-mRNA isolated from mouse (15) , primate (16) , human tonsilar (17) and peripheral blood lymphocytes (18) has been translated in Xenopus laevis oocytes, while IL2-mRNA, isolated from a human T-cell line was efficiently translated in a reticulocyte lysate (11) . Monoclonal antibodies binding human IL2 (19, 20) and monoclonal antibodies specific for the human IL2 membrane receptor (21) have been prepared. Human IL2 preparations are active on human, rat and mouse IL2-dependent cells (22) . IL2 augments NK cell-mediated cytotoxicity in addition to its activation by interferon (23) . IL2 has been used extensively for cloning various T-cell subsets (24) and NK cells (25) suggesting a potential use for specific adaptive immunotherapy of neoplasia by systemic transfer of expanded lymphoid cells (26, 27) . Deficiency in IL2 production has been shown to occur in certain diseases characterized by immunodeficiencies (28, 29) supporting its essential role for the full expression of the human immune response.
In this report, we describe the characterization of a human IL2 cDNA gene and its expression in E. coli. The method we have used for cloning the IL2 cDNA was essentially identical to the strategy used for cloning the human immune interferon (IFN-6 ) cDNA gene (30) . Recently, the human IL2 cDNA gene, derived from a T-cell leukemia was cloned and expressed in eukaryotic cells (31) . The availability of an IL2 cDNA-containing plasmid will allow for the large scale production and purification of human IL2 derived from genetically engineered cells. We also report the isolation and characterization of the human genomic IL2 gene. -80"C. The target cells were then stored in liquid nitrogen (33) .
Immediately before use, the cells were thawed rapidly at 37 C, mixed stepwise with medium and washed. Viability was examined by Trypan blue exclusion.
The IL2 microassay was performed according to Gillis et al. (4) . 100,j.l IL2 samples were serially diluted (1/2) in 96-well microtiter plates (Falcon) (in RPMI 1640, 10% fetal calf serum, 1% L-glutamine and antibiotics). The target cells were suspended at 2 x 105 cells/ml and 100lAl was supplied to the wells. Microtiter plates were incubated at 37 C for 24 h in a humidified atmosphere of 5% CO, in air. Next, 0.5pACi of 3H-labelled thymidine (Amersham [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Ci/mmole) was added to each microDlate well and cultured for an additional 5 h. Cultures were harvested onto glass filter strips (with a cell-harvester; type MASH II). 3H-Thymidine incorporation was determined with a liquid scintillation counter.
The standard (an arbitrarily chosen human IL2 containing supernatant)
was defined as containing 100 U/ml and induced maximal proliferation up to dilutions of 1/4 to 1/8 as measured by 3H-thymidine uptake. 30% of the maximal activity of this sample was usually located in the centre of the linear descending part of the standard curve. Each test sample was also tested at serial dilutions and the titre was calculated by a graphical regression analysis. The activity in each test sample was converted into units according to Stadler et al. (20) .
Construction and screening of cDNA plasmids
Human splenocytes from an individual donor were isolated (37) and cultured for 20 h at 37 C in the presence of PHA (10 ,u-gml') and TPA (10 ngml').
Total RNA was extracted (34) (40), microinjection into Xenopus laevis oocytes and assay of the oocyte medium for IL2 activity yielded 2 filters, M3-2 and M3-6, which gave a clear positive signal (Table I) . Subsequent hybridization of filters containing "insert-DNA" derived from 14 different subgroups (each containing 7 clones) from the group M3-2 with IL2-mRNA, led to the identification of the IL2-cDNA-containing plasmid (M3-2-32, Fig lA) . This was confirmed by hybridizing a filter containing only "insert-DNA" isolated from clone M3-2-32 with IL2-mRNA (Fig lB) . This first positive clone was renamed pSV-HIL2-0. Gel electrophoresis revealed that the Bam HI excised "insert-DNA" was approximately 750 bp in length. Colony hybridization (43, 44) of 1300 colonies from group M2 and 1050 from group M3 with a 5;P-labelled (45) internal Hinf fragment (500 bp) derived from pSV-HIL2-0 resulted in the identification of one additional clone (M3-6-41, designated pSV-HIL2-l) in the group M3. This second clone is derived from group M3-6 which gave a positive signal in the first hybridization-elution translation screening assay (Table I ). The Bam HI excised "insert-DNA", derived from the pSV-HIL2 plasmid preparations was purified by sucrose gradient centrifugation and mapped using restriction enzymes. Further characterization of these insert-DNAs revealed that the insert present in pSV-HIL2-l was only 250 bp in length and corresponded to an internal sequence within "insert-DNA" derived from pSV-HIL2-0. Such a small insert DNA probably originated through internal dG-tailing at a nick present in the sized ds-cDNA. 3. Nucleotide sequence of the human IL2-cDNA gene and deduced amino acid sequence a.Characterization of the "insert-DNA" derived from pSV-HIL2-0 Fig. 2 shows a physical map of the IL2 gene together with the sequencing strategy and the restriction map. The nucleotide sequence of the insert derived from plasmid pSV-HIL2-0 and completed with sequence information from the genomic clone is shown in Fig. 3 coli BHB 2600 were screened in situ (53) using a 32P-labelled IL2-cDNA specific Hinf fragment derived from PAT153-HIL2 (see next section). A total of 5 hybridization-positive phage plaques were isolated from the two banks. One of these (;kCH4A-gHil2-l) was shown to contain the total human IL2-gene and was analysed in further detail. The total IL2 gene was then subcloned in pUR250 (54) as two Eco RI restriction endonuclease fragments (pUR-gHil2-1 and pUR-gHil2-2). pUR-gHil2-1 was shown both by restriction analysis and hybridization data to contain the promoter region and the 5'-part of the transcribed human IL2 gene. Detailed restriction analysis of both subclones gave evidence for the presence of at least two introns in the coding region (data to be reported elsewhere). Ref: 5' _labeled HaeIII digest of X174-DNA was used as size markers. pSV-HIL2-0, the presence of this ATG codon results in a 5' non-coding region of approximately 50 nucleotides. We have renumbered our nucleotide sequence on the basis of the results obtained on a presumably complete human IL2 cDNA clone reported recently by Taniguchi et al. (31) . Indeed, our sequence data revealed the presence of a TATAAAT-concensus segment, typical for a eukaryotic promoter at position -32 nucleotides as expected. A putative signal peptide sequence of 20 amino acids can be identified (Fig. 3) , cleavage of which results in a mature polypeptide of 133 amino acids having a molecular weight of 15,400. The amino acid sequence shows an almost identical number of basic and acidic residues, explaining the neutral pI value observed for the natural human IL2 (3). The polypeptide sequence contains three cysteine residues, two of which might be involved in an intramolecular disulfide bridge.
The nucleotide sequence we have determined for the IL2 mRNA and amino acid sequence deduced for IL2 is in complete agreement with the data obtained by Taniguchi et al. except for the nucleotide at position 503 which we determined to be G as opposed to A. This substitution does not lead to a change in the amino acid sequence. It should be noted that our clone was derived from normal splenocytes while the one of Taniguchi et al. (31) was derived from the human Jurkat 111 cell line. Also, our assays were done on human PBL while Taniguchi et al. used the mouse cell line CTLL-2. The lack of a potential N-glycosylation site explains why IL2 is not retained on lectin columns (3) . The change in heterogeneity of the pI value after treatment with neuraminidase (14) and the observed heterogeneity in molecular weight distribution after induction of IL2 by different stimuli (13) remains to be explained. (46) . Expression studies with vectors using the PL promoter were carried out in strain K12aHlsetrp (47) . Threinitiatin grown at28-C and induced at 42°C (46) . Induction of the trp promoter was obtained after tryptophan starvation of strain K514;k (48) . To test for biological activity of bacterially synthesized human IL2, the cells were opened by sonication; cell debris was spun down and the supernatant was passed through a 0.2,a Millipore filter. These extracts were then assayed for T-cell growth activity. From the results shown in Table 2 , it can be concluded that extracts of induced cultures contain IL2 activity, while similar extracts from uninduced cultures scored negative. Both the protein initiating with Met-Ala-Pro, as well as the one initiating with Met-Pro, were biologically- (containing pTrp-Hil2 plasmids) grown at 373 C and induced by depletion of exogenous tryptophan) were concentrated 10 fold. The cells were lysed by sonication. The extracts were centrifuged, passed through a 0.2A
Millipore filter and assayed for IL2 activity as described in Materials and Methods. 1, 10 and 100A-1 of each sample were used at serial dilutions (1/2) and 3H-thymidine incorporation by PHA-stimulated human peripheral blood lymphocytes was measured. IL2 was quantified as described (4, 20, 33 (Fig 6.A) . The biological activity found in the cleared extracts ( 
